Table 1 Patient characteristics (n = 84)
Characteristic | Whole population (n = 84) Number (%) |
|---|---|
Median age, years (range) | 50.5(28–70) |
Amenorrhea | |
Premenopausal | 36 (42.9) |
Postmenopausal | 48 (57.1) |
Advanced or metastatic | |
De novo metastatic | 12 (14.3) |
Metastatic | 72 (85.7) |
No. of metastatic sites | |
1 | 6 (7.1) |
2 | 31 (36.9) |
≥ 3 | 47 (56.0) |
Metastatic sites | |
Visceral | 69 (82.1) |
Lung | 39 (46.4) |
Liver | 48 (57.1) |
Non-visceral | 15 (17.9) |
Bone | 46 (54.8) |
Subgroup | |
Luminal | 61 (72.6) |
Triple-negative | 12 (14.3) |
HER2 positive | 10(11.9) |
Unknown | 1(1.2) |
Lines of chemotherapy | |
First line | 59(70.2) |
Second line or more line | 25(29.7) |
Prior chemotherapy | |
Adjuvant/neoadjuvant (n = 65) | |
Anthracycline-containing | 63 (96.9) |
Taxane-containing | 49 (75.4) |
Both | 47 (72.3) |
Chemotherapy for MBC (n = 25) | |
Anthracycline-containing | 6 (24) |
Taxane-containing | 10 (40) |
Both | 3(12) |